(CNN) – The efficacy of Chinese vacancies against covid-19 “is not high” and the authorities have options to enforce the protection, including the various injecting measures, said the Chief Enforcement Officer of China.
“The protection cases of existing vacancies are not high”, said Gao Fu, Director of the Chinese Center for Control and Prevention of Sickness, at a conference on Chengdu’s surface accident on Saturday.
Enumerate options to solve the problem: one will increase the dose number or adjust the dose or the interval between injections; the other is mezclar vacancies unrolled due to different technologies.
Gao Fu, Director of Centro Chino para el Control y la Prevention de Enfermedades, held at the National Conference of Vacancies and Health in Chengdu, Sichuan Province, on Saturday.
Gao’s comments are a public outcry, shared by the main health officer of the country, that the efficiency of vacancies against China’s coronavirus is not ideal and that it is necessary to increase protection.
China is positioned as leader in the development and distribution of the vaccine against covid-19, promoting and administering its vaccines to countries around the world, including Indonesia, Zimbabwe, Turkey and Brazil.
«More than 60 countries have approved the use of the Chinese vaccine. The security and efficacy of China’s vacancy is being widely recognized by various countries, “said Chinese Foreign Minister Wang Yi at a March press conference.
Without embarrassment, the relative efficiency of China’s vacancies could undermine the credibility and reputation of Beijing’s diplomacy.
The pharmaceutical companies that summarize the majority of vacancies against covid-19 Chinese worldwide have not published complete clinical trial reports on the efficacy of their vacancies. In addition to the provisional results announced by the companies, its efficiency is very much for the sake of the new type of vacancies developed in Occidente that use ARNm technology to launch an independent response.
It was found that the CoronaVac vaccine, developed by Sinovac, has a private enterprise, has a 50.4% only efficacy case in clinical trials in Brazil. Another single in Turkey shows that it has 83.5% efficiency. Sinopharm states that its vacancies have efficiencies of 79.4% and 72.5%.
In comparison, the vehicles of Pfizer-BioNTech and Modern have efficiencies of 97% and 94%, respectively.
In March, the United Arab Emirates began to offer a third dose of the Sinopharm vaccine to residents who could not generate enough anti-infective drugs after two injections.
In this sense, Gao’s comments about the relatively low efficiency of Chinese vacancies indicate a very well known, but it was the first time that a high – level official in China publicly reconciled.
The comments of the jefe of the CDC of China also are produced when the country is intensifying its campaign for home eviction. Hasta el viernes, China, controlled the 160 million dose of the vaccine against covid-19. Its target is inoculated to 40% of its 1,400 million residents by June’s finals.
“The most surprising thing is that the sufficiency of the bags of efficiency relatively low in the Chinese vacancies appears to be a deviation from what the Chinese state and the social networks say. The official narrative describes Chinese vacancies as security and effectiveness, ”said Yanzhong. Huang, member principal of Consejo de Relaciones Exteriores, held the public discussion of Gao and Twitter during the fin de semana.
While Gao’s comments are groundbreaking in the social and legal speeches on international headlines, Chinese censors are rapidly eliminating online discussions and state media and will publish a one-on-one interview with Gao to retire from his comments.
Global Times, a tabloid nationalist, states that Gao claims that the information about his release is “completely misunderstood”.
“The protection bags of all the vacancies in the world are high and other beds. Cómo mejarar su efficia is a question that scientists of the world should consider “, says Gao, says.
Huang, China’s public health expert, said the Global Times’ rapid response suggested that Chinese authorities would not tolerate any challenge to their official narrative.
“Gao’s comments were just an occasional aberration,” he said.
Additional information from Reuters.